Zeltiq Announces Third Quarter 2015 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Zeltiq Announces Third Quarter 2015 Financial Results

PLEASANTON, CA --(Marketwired - October 27, 2015) -

  • 337 systems shipped, compared to 260 systems in third quarter 2014, bringing total system installed base to 4,247 systems
  • 247,298 revenue cycles, up 55% from third quarter 2014
  • Third quarter GAAP net income of $2.1 million, or $0.05 per share
  • Third quarter Adjusted EBITDA of $5.6 million, or 9.2% of total revenue

ZELTIQ ® , ( NASDAQ : ZLTQ ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced financial results for the third quarter 2015.

Mark Foley, President and Chief Executive Officer, said, "I am very pleased with our ongoing, successful execution and our ability to continue to expand and grow the non-invasive fat reduction market which we believe remains in its early stages of evolution. Our third quarter revenue of $61.2M reflects the significant momentum we are experiencing, our expanding leadership position and our ability to continue to penetrate the largely untapped $4 billion non-invasive fat reduction market. In the quarter, over 50% of our revenue came from consumables and our 34% year-over-year total revenue growth was driven by our ninth consecutive quarter of year-over-year account utilization growth. These results and our expectations for the fourth quarter have led us to raise our full year revenue guidance to approximately $252 million."

Mr. Foley continued, "I am also pleased with the progress we continue to make on our strategic initiatives which include new product introductions, expanded indications, increasing brand awareness, shorter treatment times and increasing account utilization. In the third quarter we expanded our direct-to-consumer pilot, continued the successful roll out of our CoolSmooth PRO™ applicator, received FDA clearance to treat submental fat and launched our CoolMini applicator. Early feedback on our CoolMini applicator and its ability to treat submental fat has been very positive and we are excited about the significant new market opportunity CoolMini opens up and its ability to bring new patients into the aesthetic channel. Our CoolSmooth Pro applicator continues to receive positive feedback as more physicians experience the economic and convenience benefits of a shorter treatment time and better practice efficiency. In addition, we remain on track to introduce colder temperatures to our suction-based applicators in 2016 which we believe will enable our practices to reduce treatment times by almost half. Our direct-to-consumer pilot continues to generate positive results and our expansion into seven additional U.S. cities and one international market is having a measurable effect. Lastly, we are pleased to announce that we entered into a collaboration and license agreement with Massachusetts General Hospital (MGH) for the treatment of acne. The agreement provides ZELTIQ with the rights, on an exclusive worldwide basis, to the intellectual property generated from the collaboration. As part of this, we will be paying MGH a 3% royalty for any future products that are commercialized under this agreement. We have confidence that our technology, strategic initiatives, deep pipeline, marketing expertise and compelling practice economics will continue to drive robust top-line growth."

Third Quarter Financial Review

Total revenue for the third quarter 2015 was $61.2 million, consisting of $29.3 million of system revenue and $31.9 million of consumable revenue. This compares to total revenue of $45.7 million, consisting of $24.8 million of system revenue and $20.9 million of consumable revenue for the third quarter 2014. Total revenue cycles shipped increased 55% to 247,298 for the third quarter 2015, compared to 159,116 for the third quarter 2014.

Gross profit was $45.2 million, or 74% of revenue, for the third quarter 2015, compared to gross profit of $33.1 million, or 73% of revenue, for the third quarter 2014. Operating expenses for the third quarter 2015 were $43.2 million, compared to $28.2 million for the third quarter 2014.

Income from operations for the third quarter 2015 was $1.9 million, compared to $5.0 million for the third quarter 2014. Net income for the third quarter 2015 was $2.1 million, or $0.05 per share, compared to $4.8 million for the third quarter 2014, or $0.12 per share. Weighted average diluted shares outstanding was 40.9 million for the third quarter 2015 and 2014.

On a non-GAAP basis, the Company reported adjusted EBITDA of $5.6 million, or 9% of revenue, for the third quarter 2015, compared to $7.9 million, or 17% of revenue, for the third quarter 2014.

Cash and cash equivalents, short-term investments, and long-term investments were $50.5 million as of September 30, 2015 compared to $48.1 million as of September 30, 2014, and $53.1 million as of June 30, 2015.

Revised Full Year 2015 Financial Guidance

ZELTIQ is updating its previously stated financial guidance for the full year 2015, provided on its second quarter 2015 earnings conference call:

  • Revenue guidance of approximately $252 million which includes approximately $3 million of currency headwinds; up from prior guidance of $245 million to $247 million
  • Consumable revenue of approximately 50% of total revenue; unchanged from prior guidance
  • Gross profit margin of approximately 71% of total revenue; unchanged from prior guidance
  • Operating expenses of approximately 69% of total revenue; improved from prior guidance of 69% to 70%
  • Stock-based compensation, depreciation, and amortization expense of approximately 7% of total revenue; unchanged from prior guidance
  • Adjusted EBITDA margin of approximately 9% of total revenue; up from prior guidance of 8% to 9%

Additional information regarding ZELTIQ's results and guidance can be found in ZELTIQ's Supplemental Financial and Operational Information schedule by CLICKING HERE or by visiting the Investor Relations section of ZELTIQ's website at www.zeltiq.com .

Use of Non-GAAP Financial Measures

ZELTIQ has supplemented its GAAP net income (loss) with a non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP financial measure provides useful supplemental information to management and investors regarding the performance of ZELTIQ, facilitates a more meaningful comparison of results for current periods with previous operating results, and assists management in analyzing future trends, making strategic and business decisions and establishing internal budgets and forecasts. A reconciliation of non-GAAP Adjusted EBITDA to GAAP net income (loss) in the most directly comparable GAAP measure is provided in the schedule below.

There are limitations in using this non-GAAP financial measure because it is not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. This non-GAAP financial measure should not be considered in isolation or as a substitute for GAAP financial measures. Investors and potential investors should consider non-GAAP financial measures only in conjunction with ZELTIQ's consolidated financial statements prepared in accordance with GAAP and the reconciliations of the non-GAAP financial measure provided in the schedule below.

Conference Call

ZELTIQ will hold a conference call on Tuesday, October 27, 2015 at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results. The dial-in numbers are (877) 280-7291 for domestic callers and (707) 287-9361 for international callers. The conference ID number is 55676149. A live webcast of the conference call will be available online from the investor relations page of the company's corporate website at www.coolsculpting.com .

A replay of the webcast will remain available on ZELTIQ's website, www.coolsculpting.com , until ZELTIQ releases its fourth quarter 2015 financial results. In addition, a telephonic replay of the call will be available until November 3, 2015. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Please use the replay conference ID number 55676149.

About ZELTIQ ® Aesthetics

ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting ® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.

Forward-Looking Statements

The statements made in this press release regarding ZELTIQ's estimate of the worldwide opportunity of $4B, its belief that CoolMini offers a sizable new market opportunity, its belief that it is on track to introduce colder temperatures to its suction-based applicators in 2016, its belief that such introduction will enable practices to reduce treatment times by almost half, its growth prospects and financial projections for the full year 2015, and its confidence in its recently stated long term financial objectives, are forward-looking statements. The words "believe," "expect," "will", and "guidance" and similar words that denote future events or results identify these forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond ZELTIQ's control and that could materially affect ZELTIQ's actual business operations and financial performance and condition. Factors that could materially affect ZELTIQ's business operations and financial performance and condition include, but are not limited to: less than anticipated growth in the number of physicians electing to purchase CoolSculpting Systems; patient demand for CoolSculpting procedures may be lower than ZELTIQ expects; product or procedure announcements by competitors may decrease demand for CoolSculpting procedures; ZELTIQ may incorrectly estimate or control its future expenditures; ZELTIQ may incorrectly estimate the timing of new product development and new product launch; ZELTIQ's sales and marketing plans may fail to increase sales as ZELTIQ expects; individual patients may not experience the same results with CoolMini as the average patient in the clinical trials; as well as those other risks and uncertainties set forth in ZELTIQ's Quarterly Report on Form 10-Q for the second quarter ended June 30, 2015, filed with the SEC on July 30, 2015. These forward-looking statements speak only as of the date of this press release. ZELTIQ expressly disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events or otherwise.

         
 
ZELTIQ Aesthetics, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
         
    September 30, 2015   December 31, 2014
ASSETS        
CURRENT ASSETS:            
  Cash and cash equivalents   $ 35,618   $ 28,649
  Short-term investments     11,235     16,286
  Accounts receivable, net     32,908     21,472
  Inventory     28,783     15,536
  Prepaid expenses and other current assets     8,716     7,060
    Total current assets     117,260     89,003
  Long-term investments     3,620     4,805
  Restricted cash     459     560
  Property and equipment, net     4,770     3,724
  Intangible asset, net     5,255     5,780
  Other assets     147     33
    Total assets   $ 131,511   $ 103,905
             
LIABILITIES AND STOCKHOLDERS' EQUITY            
CURRENT LIABILITIES:            
  Accounts payable   $ 12,159   $ 5,824
  Accrued and other current liabilities     32,019     21,450
  Deferred revenue     7,198     5,069
  Current portion of capital lease obligations     123     120
    Total current liabilities     51,499     32,463
Long-term deferred revenue     157     622
Long-term capital lease obligations, less current portion     170     262
Other non-current liabilities     568     39
    Total liabilities   $ 52,394   $ 33,386
STOCKHOLDERS' EQUITY:            
    Total stockholders' equity     79,117     70,519
    Total liabilities and stockholders' equity   $ 131,511   $ 103,905
                 
 
 
ZELTIQ Aesthetics, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share data)
(Unaudited)
                 
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
    2015   2014   2015   2014
Revenue   $ 61,202   $ 45,670   $ 177,191   $ 123,706
Cost of revenue     16,041     12,555     48,535     35,231
  Gross profit     45,161     33,115     128,656     88,475
Operating expenses:                        
  Research and development     5,464     4,241     17,352     12,861
  Sales and marketing     30,647     19,014     87,253     60,253
  General and administrative     7,115     4,896     22,156     14,843
    Total operating expenses     43,226     28,151     126,761     87,957
Income from operations     1,935     4,964     1,895     518
Interest income, net     13     14     40     47
Other income (expense), net     359     (189)     (508)     (338)
Income before income taxes     2,307     4,789     1,427     227
Provision for income taxes     160     7     231     13
Net income     2,147     4,782     1,196     214
Net income per share, basic   $ 0.06   $ 0.13   $ 0.03   $ 0.01
Weighted average shares of common stock outstanding used in computing net income per share, basic     38,881,183     37,630,222     38,640,269     37,430,337
Net income per share, diluted   $ 0.05   $ 0.12   $ 0.03   $ 0.01
Weighted average shares of common stock outstanding used in computing net income per share, diluted     40,860,593     40,926,034     40,724,261     40,781,141
                         
                         
             
ZELTIQ Aesthetics, Inc.  
Condensed Consolidated Statements of Cash Flows  
(In thousands)  
(Unaudited)  
    Nine Months Ended  
    September 30,  
    2015     2014  
CASH FLOWS FROM OPERATING ACTIVITIES:                
  Net income   $ 1,196     $ 214  
  Adjustments to reconcile net income to net cash provided by (used in) operating activities:                
    Depreciation and amortization     1,712       1,350  
    Stock-based compensation     10,261       7,029  
    Deferred income taxes     -       37  
    Amortization of investment premium, net     63       183  
    Provision for doubtful accounts receivable     270       134  
    Provision for excess and obsolete inventory     403       688  
    Loss on disposal and write-off of property and equipment     -       17  
    Changes in operating assets and liabilities:                
      Accounts receivable     (11,773 )     (5,653 )
      Inventory     (13,698 )     (9,684 )
      Prepaid expenses and other assets     (1,794 )     177  
      Deferred revenue, net of deferred costs     1,681       2,426  
      Accounts payable, accrued and other liabilities     17,573       (2,076 )
      Net cash provided by (used in) operating activities     5,894       (5,158 )
CASH FLOWS FROM INVESTING ACTIVITIES:                
  Purchase of investments     (12,079 )     (9,011 )
  Proceeds from sale of investments     -       1,000  
  Proceeds from maturity of investments     18,260       14,968  
  Purchase of property and equipment     (2,332 )     (1,216 )
  Change in restricted cash     94       (252 )
    Net cash provided by investing activities     3,943       5,489  
CASH FLOWS FROM FINANCING ACTIVITIES:                
  Principal payments on capital leases     (89 )     -  
  Proceeds from issuance of common stock upon exercise of stock options and from employee stock purchase plan     4,136       2,714  
  Tax payments related to shares withheld for vested restricted stock units     (6,577 )     (3,774 )
  Tax effect of employee stock plans     26       27  
    Net cash used in financing activities     (2,504 )     (1,033 )
Effect of exchange rate changes on cash and cash equivalents     (364 )     (155 )
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS     6,969       (857 )
CASH AND CASH EQUIVALENTS-Beginning of period     28,649       25,798  
CASH AND CASH EQUIVALENTS-End of period   $ 35,618     $ 24,941  
                         
   
   
ZELTIQ Aesthetics, Inc.  
Reconciliation of Net Income to Adjusted Earnings Before Interest, Taxes, Depreciation,  
Amortization and Stock-Based Compensation (Adjusted EBITDA)  
(In thousands, except for percentages)  
(Unaudited)  
                         
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
Dollars   2015     2014     2015     2014  
  Net income, as reported   $ 2,147     $ 4,782     $ 1,196     $ 214  
                                 
  Adjustments to net income:                                
    Interest income, net and other income (expense), net     (372 )     175       468       291  
    Provision for income taxes     160       7       231       13  
    Depreciation and amortization     650       417       1,712       1,350  
    Stock-based compensation expense     3,028       2,518       10,261       7,029  
      Total adjustments to net income     3,466       3,117       12,672       8,683  
                                 
  Adjusted EBITDA   $ 5,613     $ 7,899     $ 13,868     $ 8,897  
                                 
                                 
      Three Months Ended       Nine Months Ended  
      September 30,       September 30,  
As a Percentage of Revenue     2015       2014       2015       2014  
  Net income, as reported     3.5 %     10.5 %     0.7 %     0.2 %
                                 
  Adjustments to net income:                                
    Interest income, net and other income (expense), net     -0.6 %     0.4 %     0.2 %     0.2 %
    Provision for income taxes     0.3 %     0.0 %     0.1 %     0.0 %
    Depreciation and amortization     1.1 %     0.9 %     1.0 %     1.1 %
    Stock-based compensation expense     4.9 %     5.5 %     5.8 %     5.7 %
      Total adjustments to net income     5.7 %     6.8 %     7.1 %     7.0 %
                                 
  Adjusted EBITDA Margin     9.2 %     17.3 %     7.8 %     7.2 %
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 201

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 311

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 274

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 173

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 162

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 138

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 252

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 237

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 308

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Robinhood Markets Shares November 2025 Operational Highlights

Updated Category News Views 269

Robinhood Markets Releases November 2025 Operational Highlights Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) has recently shared its monthly operating data for November 2025, offering an insightful look into its operational metrics and customer engagement. This report emphasizes key growth indicators and trading volume achievements over the month, reflecting...

Continue Reading
Gold Prices Decline Amid Anticipation of Federal Reserve Actions

Updated Category News Views 140

Gold Prices Drop as Federal Reserve Meeting Commences Gold prices experienced a decline as traders adjusted their positions ahead of the Federal Reserve's crucial meeting. The latest updates signal a decrease in spot gold prices, which now hover around $2,646.06 an ounce. Similarly, gold futures, set to expire in February, showed a minor drop to $2,662.44 an ounce. This...

Continue Reading
Understanding Adobe's Current Stock Performance Analysis

Updated Category News Views 239

Market Dynamics of Adobe Inc. Investors are taking a closer look at Adobe Inc (NASDAQ: ADBE) as they adopt varying strategies in the options market. Notably, deep-pocketed investors have shown bearish tendencies, making it a key point of interest for those monitoring market movements. Recent observations have highlighted an unusual upsurge in options activities related to...

Continue Reading
NexPoint Diversified Real Estate Trust's New Preferred Share Offering

Updated Category News Views 212

NexPoint Diversified Real Estate Trust Announces Major Offering NexPoint Diversified Real Estate Trust (NYSE: NXDT), a leading player in the real estate investment trust sector, has unveiled an opportunity for investors with a continuous public offering of its 9.00% Series B Cumulative Redeemable Preferred Shares. With a planned issuance of up to 16,000,000 shares, the...

Continue Reading
Outbrain Dominates the Q4 2024 France Ad Seller Rankings

Updated Category News Views 185

Outbrain Leads the Way in France's Q4 2024 Ad Rankings In a recent release, Pixalate has highlighted the leading programmatic ad sellers in France for the fourth quarter of 2024. This report emphasizes the importance of quality within the digital advertising ecosystem, offering a glimpse into the companies making significant strides in this sector. Understanding the...

Continue Reading